- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 453
Wejo raises new funds
The GM-backed transport data provider has added $13.1m in a round led by existing investor DIP Capital and backed by the UK’s Future Fund.
Aug 6, 2020DeepX dives for $15m
Fujita, Industrial Growth Platform and SBI were among the investors in the automation technology developer, a spinout of University of Tokyo.
Aug 6, 2020Daily deal net: August 6, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 6, 2020GentiBio engenders $20m
Novartis Venture Fund has helped seed a T-cell drug developer founded from Seattle Children's Hospital, Benaroya Research Institute and MIGAL Galilee.
Aug 6, 2020Lepu Biotech leaps to $186m series B
Lepu Medical's immuno-oncology spinoff secured $186m in a round co-led by Ping An Capital and the Sunshine Insurance-backed Riverhead Capital.
Aug 6, 2020ChargePoint chases down another $127m
American Electric Power and Chevron Technology Ventures were among the existing investors that helped the EV charging service boost its overall funding to $667m.
Aug 6, 2020Yotpo's series E round yields $75m
Access Industries was among the returning investors in a $75m round that brought marketing platform Yotpo’s overall funding to $176m.
Aug 6, 2020Syntiant talks about $35m series C round
M12 and Applied Ventures co-led a $35m round for Syntiant, which is working on chips for artificial intelligence-powered voice processing at the edge.
Aug 6, 2020GentiBio generates $20m in seed funding
The T-cell drug developer has launched with $20m from a seed round co-led by corporate venturing unit Novartis Venture Fund.
Aug 6, 2020MicuRx sends for Sinopharm in series D
Sinpoharm-backed joint venture Sinopharm-CICC was among the investors in a $43.2m round that boosted the antimicrobial drug developer's total funding to near $150m.
Aug 6, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


